DC661
Based on 6 publication(s) in Google Scholar
DC661 is a potent palmitoyl-protein thioesterase 1 (PPT1) inhibitor, inhibits autophagy, and acts as an anti-lysosomal agent. Anti-cancer activity.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 99.53%
- CAS No.: 1872387-43-3
- 화학식: C31H39Cl2N5
- 분자량:552.58
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) DC661
More- Nat Biotechnol. 2022 Dec;40(12):1834-1844. [Abstract]
- Mol Cell. 2024 Apr 18;84(8):1556-1569.e10. [Abstract]
- Nat Chem Biol. 2025 May 26. [Abstract]
- J Immunother Cancer. 2023 Jun;11(6):e006655. [Abstract]
- Biosci Rep. 2023 May 31;43(5):BSR20230067. [Abstract]
- Res Sq. 2025 Feb 11:rs.3.rs-4138879. [Abstract]
-
WB
-
RT-PCR
-
Flow Cytometry
-
In Vivo Efficacy Study
-
Cell Imaging/Staining
Biological Activity
PPT1, autophagy[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A375P | IC50 |
0.49 μM
Compound: 2; DC661
|
Cytotoxicity against human A375P cells incubated for 72 hrs by MTT assay
Cytotoxicity against human A375P cells incubated for 72 hrs by MTT assay
|
[PMID: 34298133] |
DC661 (0.1 and 10 μM) accumulates autophagic vesicles in melanoma cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 1872387-43-3
-
Appearance Solid
-
분자량 552.58
-
화학식 C31H39Cl2N5
-
Color White to yellow
-
SMILES
CN(CCCCCCNC1=CC=NC2=CC(Cl)=CC=C12)CCCCCCNC3=CC=NC4=CC(Cl)=CC=C34
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Nat Biotechnol
2022 Dec;40(12):1834-1844. PMID: 35879364 -
Mol Cell
2024 Apr 18;84(8):1556-1569.e10. PMID: 38503285 -
Nat Chem Biol
2025 May 26. PMID: 40419770 -
J Immunother Cancer
Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma. [Abstract]2023 Jun;11(6):e006655. PMID: 37385725
DC661 purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2023 Jun;11(6):e006655. [Abstract]
Western blot of MAPK and NF-κB signaling pathways in THP-1-differentiated macrophages treated with the DMSO and DC661.
DC661 purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2023 Jun;11(6):e006655. [Abstract]
qPCR analyses of the indicated genes in DMSO and DC661 treatment groups.
DC661 purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2023 Jun;11(6):e006655. [Abstract]
Flow cytometry analysis of CD80, galectin-9, and CD172a expression in DMSO and DC661 treatment groups.
DC661 purchased from MedChemExpress. Usage Cited in: J Immunother Cancer. 2023 Jun;11(6):e006655. [Abstract]
Gross appearance of the subcutaneous HCC tumors treated with DC661 (30 mg/kg, i.p.).
-
Biosci Rep
Identification of PPT1 as a lysosomal core gene with prognostic value in hepatocellular carcinoma. [Abstract]2023 May 31;43(5):BSR20230067. PMID: 37103469
DC661 purchased from MedChemExpress. Usage Cited in: Biosci Rep. 2023 May 31;43(5):BSR20230067. [Abstract]
Representative images and quantification of colony formation assay. HCC cells were chronically treated with DC661 (2 μM, 10 days) for colony formation assays.
-
Res Sq
2025 Feb 11:rs.3.rs-4138879. PMID: 39989975
용액&용해도
DMSO : 62.5 mg/mL (113.11 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (267 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.8097 mL | 9.0485 mL | 18.0969 mL | 45.2423 mL |
| 5 mM | 0.3619 mL | 1.8097 mL | 3.6194 mL | 9.0485 mL | |
| 10 mM | 0.1810 mL | 0.9048 mL | 1.8097 mL | 4.5242 mL | |
| 15 mM | 0.1206 mL | 0.6032 mL | 1.2065 mL | 3.0162 mL | |
| 20 mM | 0.0905 mL | 0.4524 mL | 0.9048 mL | 2.2621 mL | |
| 25 mM | 0.0724 mL | 0.3619 mL | 0.7239 mL | 1.8097 mL | |
| 30 mM | 0.0603 mL | 0.3016 mL | 0.6032 mL | 1.5081 mL | |
| 40 mM | 0.0452 mL | 0.2262 mL | 0.4524 mL | 1.1311 mL | |
| 50 mM | 0.0362 mL | 0.1810 mL | 0.3619 mL | 0.9048 mL | |
| 60 mM | 0.0302 mL | 0.1508 mL | 0.3016 mL | 0.7540 mL | |
| 80 mM | 0.0226 mL | 0.1131 mL | 0.2262 mL | 0.5655 mL | |
| 100 mM | 0.0181 mL | 0.0905 mL | 0.1810 mL | 0.4524 mL |